What does CUSIP 874060205 represent in this 13F holders report?

CUSIP 874060205 is the security identifier for TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS used to aggregate holder disclosures.

How many institutions held TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in Q1 2025?

300 institutional investors reported TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS for Q1 2025. Use the holders table for investor-level position and value details.

TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

CUSIP: 874060205

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / SPONSORED ADS
Total 13F shares: 71,086,493
Share change: -363,541
Total reported value: $1,057,034,943
Put/Call ratio: 2.5%
Reported price per share: $14.87
Number of holders: 300
Value change: -$156,054
Number of buys: 161
Number of sells: 124

Security key

874060205

Report period

Q1 2025

Institutions

300

Top holders

TAK full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2025 Previous quarter: Q4 2024 TAKEDA PHARMACEUTICAL CO LTD SEC filings TAKEDA PHARMACEUTICAL CO LTD company facts TAKEDA PHARMACEUTICAL CO LTD 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 874060205

Newer quarter: Q2 2025 Previous quarter: Q4 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Capital Research Global I...

13D/G signal

—

Evidence rows

Latest as of

31 Dec 2024

13F Highest disclosed value: $174,271,672 Showing 1-6 of 15 holder rows.

Rank 1 holder

Capital Research Global Investors

13F

Ownership: —
Position: $174.27M

13F

Rank 2 holder

MORGAN STANLEY

13F

Ownership: —
Position: $74.15M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital Research Global Investors	13F Company 13F	— class O/S missing	$174,271,672 13,162,513 shares	—	31 Dec 2024
MORGAN STANLEY	13F Company 13F	— class O/S missing	$74,154,959 5,600,825 shares	—	31 Dec 2024
GOLDMAN SACHS GROUP INC	13F Company 13F	— class O/S missing	$61,279,866 4,628,389 shares	—	31 Dec 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F Company 13F	— class O/S missing	$55,824,779 4,216,373 shares	—	31 Dec 2024
FMR LLC	13F Company 13F	— class O/S missing	$44,834,454 3,386,288 shares	—	31 Dec 2024
FIRST TRUST ADVISORS LP	13F Company 13F	— class O/S missing	$42,909,932 3,240,932 shares	—	31 Dec 2024

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

300

71,086,493

Rows available

300

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders

295

Q1 2025 holders

300

Holder diff

Investor	Q4 2024 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q4 2024 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend